INTRODUCING ADVANCED DRUG ANALYSIS TECHNOLOGY TO THE OPIOID EPIDEMIC.
Rigaku’s Human Infrastructure Health & Awareness (HIHA) Technology Narcotics Identification Partnership program was developed to assist government health and social administration departments and law enforcement agencies in their efforts to reduce the increasing rates of unintentional drug overdoses and fatalities, related to opioid addiction and fentanyl poisoning. Together we can play a part in making a difference in fighting the opioid epidemic that all of our communities are facing.
A SURGE IN DRUG-RELATED OVERDOSES.
As many communities are considering the decriminalization of small amounts of all hard drugs, such as cocaine, heroin, and methamphetamine, this will undoubtedly cause a surge in the use and addiction of these, and other drugs. A new, and more deadly synthetic opioid - fentanyl - is now being produced by criminal drug cartels. Drug trafficking organizations will take advantage of decriminalization to increase the distribution of fentanyl-laced drugs in smaller personal use amounts, preventing users from being arrested for drug possession. Additionally, the increase in homelessness, job loss, and clinical depression brought on a global pandemic has created a perfect storm for drug usage, and unintentional overdoses to increase.
A NEW, PROGRESSIVE APPROACH TO SAVING LIVES.
Rigaku's new Human Infrastructure Health & Awareness (HIHA) Technology partnership program would integrate our advanced drug analyzer into health and social service programs. With an extensive library of narcotics, including the latest fentanyl formations, as well as new psychoactive substances, precursor chemicals, cutting agents, and more, the Rigaku ResQ CQL can scan through packaging and be used to verify the drugs being brought into overdose prevention centers (OPC). The addition of QuickDetect Mode adds the capability to detect non-visible amounts of a substance.
LET'S WORK TOGETHER TO PREVENT THE NEXT OVERDOSE.
In an effort to support city health administrations hit the hardest by the surge in unintentional drug overdoses, Rigaku’s HIHA pilot program will provide a handheld ResQ CQL 1064 nm Raman instrument, as well as instrument and counter-drug analysis training for health administrators and their staff. Rigaku recognizes the urgency in initiating a human health and awareness program with advanced analysis technology to create safer environments for preventing drug overdose fatalities - one life at a time.